BME Proposes changes to Medical Cannabis Regulations

BME Proposes changes to Medical Cannabis Regulations - Healthcare Law Update - October 2025 - Brach Eichler
BACK TO INSIGHTS     Articles

10/1/2025

On September 15, 2025, the New Jersey Board of Medical Examiners proposed amendments to the regulations governing the use of medical cannabis. These amendments would update language used throughout the regulations to reflect the same terminology used in the Jake Honig Compassionate Use Medical Cannabis Act. Among the proposed amendments, the Board is seeking to require that physicians have a US DEA registration and complete the curriculum established by the New Jersey Cannabis Regulatory Commission in order to participate in authorizing medical cannabis use to patients. In addition, the amendments would require participating physicians to be responsible for the ongoing treatment of a patient’s qualifying medical condition. Comments to the proposed amendments are due by November 14, 2025.

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 | jfanburg@bracheichler.com
Edward Hilzenrath, HLU Editor | 973.403.3114 | ehilzenrath@bracheichler.com
Erika R. Marshall | 973.364.5236 | emarshall@bracheichler.com

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Related Practices:   Healthcare Law

Related Industry:   Healthcare